Condition
IgA Vasculitis clinical trials and research
As of November 12, 2026, Find a Trial lists 8 IgA Vasculitis clinical trials that are recruiting, at sites in 15 countries (most in United States (6), Canada (3), Japan (2)). By phase: Phase 2 (2), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 15Countries
Newest IgA Vasculitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| I-FABP as a Predictor of Gut Involvement in Pediatric IgA Vasculitis | — | Bursa, Bursa | Recruiting | Jun 24, 2026 |
| Ravulizumab for children with IgA nephropathy or IgA vasculitis nephritis | Phase 3 | Palo Alto, California and 14 other locations | Recruiting | Jun 17, 2025 |
| Which approved add-on drugs slow kidney decline in South-Asian adults with biopsy-proven IgA nephropathy? | Phase 4 | Nadiād, Gujarat and 11 other locations | Recruiting | Nov 6, 2024 |
| Treatment of pediatric kidney diseases with Sparsentan | Phase 2 | Los Angeles, California and 46 other locations | Recruiting | Aug 13, 2021 |
| Evaluating skin lesions in patients with various types of vasculitis | — | Los Angeles, California and 9 other locations | Recruiting | Dec 28, 2016 |
| Collection of tissue samples for vasculitis research | — | Boston, Massachusetts and 7 other locations | Recruiting | Nov 17, 2016 |
| Comparing treatments for isolated skin vasculitis | Phase 2 | Kansas City, Kansas and 15 other locations | Recruiting | Oct 20, 2016 |
| Registry for women with vasculitis during pregnancy | — | Tampa, Florida | Recruiting | Nov 2, 2015 |
All recruiting trials (8)
-
I-FABP as a Predictor of Gut Involvement in Pediatric IgA Vasculitis
This study checks if a blood marker called I-FABP can flag gut involvement in kids with IgA vasculitis by testing blood at diagnosis and again in 2–4 weeks.
-
Ravulizumab for children with IgA nephropathy or IgA vasculitis nephritis
This trial will test whether intravenous ravulizumab is safe and changes disease markers in children aged 2 to under 18 with biopsy‑proven IgA nephropathy or IgA vasculitis nephritis.
-
Which approved add-on drugs slow kidney decline in South-Asian adults with biopsy-proven IgA nephropathy?
This trial will test whether adding one of several approved oral medications to standard care can slow kidney function loss over two years in South-Asian adults with biopsy-proven IgA nephropathy.
-
Treatment of pediatric kidney diseases with Sparsentan
This study is testing if a new oral medication called Sparsentan can help children aged 1 to 18 with certain kidney diseases feel better and improve their condition over two years.
-
Evaluating skin lesions in patients with various types of vasculitis
This study is testing how skin lesions from different types of vasculitis look under a microscope to help doctors better understand and treat these conditions.
-
Collection of tissue samples for vasculitis research
This study is collecting tissue samples from patients with vasculitis to see if they can help researchers understand the disease better and find new ways to diagnose and treat it.
-
Comparing treatments for isolated skin vasculitis
This study is testing which of three common treatments—colchicine, dapsone, or azathioprine—works best for people with isolated skin vasculitis over a year.
-
Registry for women with vasculitis during pregnancy
This study is gathering information from pregnant women with vasculitis to understand their experiences and health outcomes during and after pregnancy.
Related topics
Quick answers
How many IgA Vasculitis clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (6 trials), Canada (3 trials), Japan (2 trials), Italy (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.